Update on biologic safety for patients with psoriasis during pregnancy
View/ Open
Published Version
https://doi.org/10.1016/j.ijwd.2016.12.003Metadata
Show full item recordCitation
Porter, Martina L., Stephen J. Lockwood, and Alexa B. Kimball. 2016. “Update on biologic safety for patients with psoriasis during pregnancy.” International Journal of Women's Dermatology 3 (1): 21-25. doi:10.1016/j.ijwd.2016.12.003. http://dx.doi.org/10.1016/j.ijwd.2016.12.003.Abstract
Biologic agents have become more common to treat patients with psoriasis, but concerns about their effect on pregnancy and lactation often preclude this treatment during these time periods. During the past decade, we have gained a much better understanding of the course of psoriasis during pregnancy and the safety of the use of biologic agents during pregnancy and lactation. Under certain circumstances, biologic agents can be considered appropriate treatment options for patients who are pregnant or lactating.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5419021/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:33029907
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)